Kenjiro Tsuruoka
Osaka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Acute Exacerbation of Pre-existing Cancer-Related Pain: An Atypical Presentation of an Amivantamab-Induced Infusion-Related Reaction.
Journal: Internal medicine (Tokyo, Japan)
Published: July 05, 2026
TTF-1 Expression and Efficacy of Platinum and Pemetrexed Plus Pembrolizumab in Advanced Lung Adenocarcinoma.
Journal: Anticancer research
Published: October 08, 2025
A novel respiratory reactance index, frequency-dependent, and for effort-independent assessment of COPD severity using MostGraph.
Journal: Respiratory medicine
Published: October 02, 2025
Severe Drug-Induced Interstitial Lung Disease After Administration of Osimertinib as Adjuvant Treatment for Resected EGFR-Mutated NSCLC: A Case Report.
Journal: JTO clinical and research reports
Published: October 26, 2023
Comparison Between Second- and Third-generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors as First-line Treatment in Patients With Non-small-cell Lung Cancer: A Retrospective Analysis.
Journal: Anticancer research
Published: June 14, 2021
Exacerbation of autoimmune myocarditis by an immune checkpoint inhibitor is dependent on its time of administration in mice.
Journal: International journal of cardiology
Published: September 14, 2019
PD-L1 expression in neuroendocrine tumors of the lung.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: January 06, 2017
Retrospective analysis of the efficacy of chemotherapy and molecular targeted therapy for advanced pulmonary pleomorphic carcinoma.
Journal: BMC research notes
Published: November 25, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026